Line Pickering Boserup

9PUBLICATIONS
19CO-AUTHORS
Traditional Chinese medicine and treatmentsHealth psychologyEpidemiological modellingMolecular medicineAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 16, 2026
Long-Term Improvements Following Initial Migraine Response in Eptinezumab-Treated Participants With Migraine for Whom 2-4 Prior Preventive Treatments Have Failed.

Jessica Ailani, Messoud Ashina, Susanne F Awad

|Feb 11, 2026
Sustained Efficacy of Eptinezumab in Participants with Migraine for Whom Prior Preventive Treatments Failed and Who Self-reported Psychiatric Comorbidities: Post Hoc Analysis of the Placebo-controlled DELIVER Trial.

Patricia Pozo-Rosich, Cristina Tassorelli, Line Pickering Boserup

|Dec 15, 2025
Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2-4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER Trial.

Cristina Tassorelli, Amaal J Starling, Susanne F Awad

|Sep 23, 2025
Number Needed to Treat and Cost Per Responder Analysis of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in Adults for Whom Prior Preventive Treatments have Failed.

Dimos D Mitsikostas, Susanne F Awad, Rikke Kongerslev

|May 30, 2025
Pharmacokinetics and safety of eptinezumab in children and adolescents with migraine.

Andrew D Hershey, Johan Areberg, Line Pickering Boserup

|Nov 06, 2024
Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial.

Anna Gryglas-Dworak, Jack Schim, Anders Ettrup

Pageof 2

Frequent Collaborators

4 joint publications

Susanne F Awad

4 joint publications

Xin Ying Lee

2 joint publications

Patricia Pozo-Rosich

2 joint publications

Jessica Ailani